TNFSF13B and myalgic encephalomeyelitis/chronic fatigue syndrome: In contrast to serum BAFF levels, there was no significant difference between the serum APRIL levels in ME/CFS patients from KTS1-2008 (n = 28, baseline samples) and healthy controls (n = 22) (Fig 2D).